Feedback Inhibition

Principles of Enzyme Regulation and Allosteric Modulation

Enzyme regulation is essential for controlling metabolic pathways and cellular function. Inhibiting an enzyme involves binding to it, causing a conformational change in its structure, and halting or modifying its activity.

  • Active Site vs. Allosteric Site:

    • Active Site: The specific region on an enzyme where the substrate binds to undergo a catalytic reaction.

    • Allosteric Site: A secondary binding location on an enzyme distinct from the active site. When a molecule binds to an allosteric site, it induces a change in the overall three-dimensional folding of the amino acid polypeptide chain.

  • Conformational Changes:

    • Binding of an inhibitor or regulator to an allosteric site alters the 3D shape of the enzyme.

    • This structural change propagates to the active site, modifying its shape so that the substrate can no longer bind.

    • Alternatively, regulatory molecules can bind to an allosteric site to induce a structural shift that removes an existing inhibitor, restoring catalytic capability.

Feedback Inhibition and Regulatory Pathways

  • Feedback Inhibition Mechanism:

    • In a metabolic sequence, feedback inhibition occurs when a product (typically the ultimate end product of the pathway) binds to an enzyme that acts early in the sequence (often Enzyme 1).

    • The end product binds to an allosteric site on Enzyme 1, triggering a 3D shape change in the active site. This stops further substrate binding and shuts down unnecessary synthesis.

    • Example of Isoleucine: In biological amino acid synthesis, isoleucine binds to Enzyme 1 as an allosteric inhibitor, shutting down its own pathway when isoleucine levels are sufficiently high.

  • Cyclic AMP Activation of Protein Kinase A:

    • Regulation can also involve relieving inhibition to activate an enzyme.

    • Cyclic AMP (cAMP) activates Protein Kinase A by binding to a regulatory subunit (regulator).

    • When cAMP binds to the regulator, the regulator changes shape, causing the attached inhibitor to be removed. This allows Protein Kinase A to function and continue the chemical pathway.

Reversible Enzyme Inhibition

Reversible inhibition can be undone because the interactions rely on weak chemical bonds. The inhibitor dynamically binds and releases from the enzyme.

  • Competitive Inhibition:

    • Mechanism: A competitive inhibitor possesses a chemical structure similar to the enzyme's natural substrate and actively competes with the substrate for access to the active site.

    • Behavior: Operates like a game of musical chairs, where both the substrate and the competitive inhibitor compete for the exact same active site.

    • Effect of Substrate Concentration: Increasing the concentration of the substrate elevates the probability that a substrate molecule will strike and occupy the active site instead of the inhibitor, thereby increasing the rate of reaction.

    • Structural Comparison Example:

    • Para-aminobenzoic acid (PABA): The normal substrate used by bacteria in essential metabolic pathways.

    • Generic Sulfonamide: A class of synthetic antimicrobial agents whose molecular structure closely resembles PABA. Sulfonamides act as competitive inhibitors by competing with PABA for the enzyme active site.

  • Non-Competitive Inhibition:

    • Mechanism: A non-competitive (allosteric) inhibitor binds to an allosteric site rather than the active site.

    • Lack of Competition: The non-competitive inhibitor does not fight with the substrate for the active site. The substrate can still approach the active site, but because the non-competitive inhibitor is attached to the allosteric site, the active site's shape is deformed.

    • Structural Impact: The inhibitor alters the overall 3D folding of the chain of amino acids, rendering the active site non-functional for substrate binding.

Irreversible Enzyme Inhibition

Irreversible inhibition leads to permanent inactivation or destruction of the target enzyme and cannot be undone.

  • Denaturation and Destruction: Irreversible inhibitors alter or destroy the 3D structural integrity of the enzyme protein through irreversible chemical modifications or complete denaturation.

  • Key Examples:

    • Mercury: A heavy metal that binds irreversibly to enzymes, destroying their structural folding and causing total loss of catalytic function.

    • Cyanide: A potent poison that permanently inactivates key cellular respiration enzymes, preventing catalytic activity irreversibly.